Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Reflow Wins FDA Approval And Initial US Clinical Use Of The Wingman35 Crossing Catheter

October 23, 2014 – 5:00 am | Edit Post

Reflow Medical Corporation Announces FDA 510(K) Clearance And Initial US Clinical Use Of The Wingman35 Crossing CatheterSAN CLEMENTE, Calif.–(BUSINESS WIRE)–ReFlow Medical, Inc. (ReFlow) today announced FDA clearance for US commercialization of their Wingman35 Crossing Catheter for use in the peripheral vasculature as well as the first US clinical cases with…

MediciNova, Inc. Announces FDA Granted Orphan Drug Designation To MN-001 (Tipelukast) For Idiopathic Pulmonary Fibrosis (IPF)

October 23, 2014 – 5:00 am | Edit Post

LA JOLLA, Calif., Oct. 22, 2014 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced that the U.S. Food and Drug Administration (FDA) has granted orphan…

Reflow Wins FDA Approval And Initial US Clinical Use Of The Wingman35 Crossing Catheter

October 23, 2014 – 5:00 am | Edit Post

Reflow Medical Corporation Announces FDA 510(K) Clearance And Initial US Clinical Use Of The Wingman35 Crossing CatheterSAN CLEMENTE, Calif.–(BUSINESS WIRE)–ReFlow Medical, Inc. (ReFlow) today announced FDA clearance for US commercialization of their Wingman35 Crossing Catheter for use in the peripheral vasculature as well as the first US clinical cases with…

Vical Incorporated Announces News Release And Conference Call Schedule For Third Quarter 2014 Financial Results

October 23, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 23, 2014 (GLOBE NEWSWIRE) — Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three and nine months ended September 30, 2014, before the opening of trading on Thursday, October 30, and conduct a conference call and webcast to discuss…

Details For REVA Medical’s Special Meeting Of Stockholders

October 23, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 22, 2014 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold a Special Meeting of Stockholders (the “Special Meeting”) on Friday 31 October 2014 at 10:30 a.m. AEDT (which is 4:30 p.m. US PDT on Thursday, October 30, 2014). The meeting will be held at…

A new dent in HIV-1′s armor

October 22, 2014 – 5:00 pm | Edit Post

LA JOLLA–Like a slumbering dragon, HIV can lay dormant in a person’s cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.

A new chink in HIV-1′s armor

October 22, 2014 – 5:00 pm | Edit Post

LA JOLLA–Like a slumbering dragon, HIV can lay dormant in a person’s cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.

10-minute Ebola test announced

October 22, 2014 – 3:27 pm | Edit Post

San Diego’s Genalyte says test works on its commercially available platform.

Edico starts selling high-powered genome processor

October 22, 2014 – 3:00 pm | Edit Post

A super-fast genome processer is now on sale by San Diego’s Edico Genome.

J&J, GSK, Tekmira, And Others Take Next Steps To Fight Ebola

October 22, 2014 – 2:39 pm | Edit Post

There’s been distressing Ebola-related news in recent days. The deadly virus continues to spread in West Africa, with more than 4,500 fatalities now reported, and efforts to halt its spread in…
[[Click headline to continue reading.]]